SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $1,512,967,797 |
| Positions | 12 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| ORUKA THERAPEUTICS INC | ORKA | COM | $352,629,785 | 3,705,262 |
| DIANTHUS THERAPEUTICS INC | DNTH | COM | $247,325,379 | 2,537,191 |
| DAMORA THERAPEUTICS INC | DMRA | COM NEW | $226,625,130 | 8,713,000 |
| COGENT BIOSCIENCES INC | COGT | COM | $212,982,277 | 5,503,418 |
| JADE BIOSCIENCES INC | JBIO | COM NEW | $101,178,637 | 4,553,494 |
| ENLIVEN THERAPEUTICS INC | ELVN | COM | $94,173,933 | 1,855,644 |
| VIRIDIAN THERAPEUTICS INC | VRDN | COM | $93,520,347 | 5,090,928 |
| ZENAS BIOPHARMA INC | ZBIO | COM | $59,872,055 | 2,359,025 |
| CRESCENT BIOPHARMA INC. | CBIO | COM | $49,461,588 | 2,747,866 |
| APOGEE THERAPEUTICS INC | APGE | COM | $39,639,416 | 298,647 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.